Proto CC-5013-MM-020: 3-Arm Study to Determine the Efficacy and Safety of Lenalidomide (Revlimid) Plus Low-Dose Dexamethasone When Given Until Progressive Disease or for 18 Four-Week Cycles Versus the Combination of Melphalan Prednisone, and Thalidomide

  • Markowitz, Avi, (PI)

    Project: Other project

    StatusFinished
    Effective start/end date9/1/098/31/14

    Funding

    • Celgene Corporation: $42,815.00